Evidence map›Paper›PMID 35429994›Full record

ArticleThe Lancet. Infectious diseases2022

A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland.

Elsa Lorthe, Mathilde Bellon, Julie Berthelot, Grégoire Michielin, Arnaud G L'Huillier, Klara M Posfay-Barbe, Andrew S Azman, Idris Guessous, Sebastian J Maerkl, Isabella Eckerle and 2 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Lancet. Infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Simulating respiratory disease transmission within and between classrooms to assess pandemic management strategies at schools.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Elsa LortheUnit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland. Electronic address: elsa.lorthe@gmail.com.
Mathilde BellonDepartment of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Julie BerthelotUnit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
Grégoire MichielinInstitute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Arnaud G L'HuillierLaboratory of Virology, Department of Diagnostics, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Pediatrics, Gynecology & Obstetrics, Pediatric Infectious Disease Unit, Geneva University Hospitals, 1205 Geneva, Switzerland.
Klara M Posfay-BarbeDepartment of Pediatrics, Gynecology & Obstetrics, Pediatric Infectious Disease Unit, Geneva University Hospitals, 1205 Geneva, Switzerland.
Andrew S AzmanUnit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Idris GuessousDivision of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Sebastian J MaerklInstitute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Isabella EckerleLaboratory of Virology, Department of Diagnostics, Geneva University Hospitals, 1205 Geneva, Switzerland; Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
Silvia StringhiniUnit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; University Center for General Medicine and Public Health, University of Lausanne, Lausanne, Switzerland.
SEROCoV-Schools Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Disease OutbreaksHumansSchoolsSwitzerland

Identifiers

PMID35429994
PMCPMC9009838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.